laromestrocel

Advertisement

cGxPJobs Banner

Longeveron Reports New Phase 2a Laromestrocel Alzheimer’s Data

Miami, Florida | June 18, 2026 Longeveron Inc. announced that an additional clinical data analysis from its Phase 2a...

By cGxPwire Editor
June 19, 2026

Read More

Longeveron Reports Constructive FDA Meeting Ahead of ELPIS II HLHS Data Readout

MIAMI, Florida, United States – May 10, 2026 Longeveron announced details from a constructive Type C meeting with the...

By cGxPwire Editor
May 11, 2026

Read More

Advertisement

cGxPJobs

Directory